vs

Side-by-side financial comparison of PATTERSON UTI ENERGY INC (PTEN) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.3× PATTERSON UTI ENERGY INC). ResMed runs the higher net margin — 27.6% vs -2.2%, a 29.8% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs -12.7%). Over the past eight quarters, ResMed's revenue compounded faster (7.8% CAGR vs -8.4%).

Patterson UTI Energy Inc. is a leading oilfield services provider offering onshore contract drilling, pressure pumping, well completion and related support services. It primarily serves upstream oil and gas operators across North America, operating in major unconventional resource basins including shale and tight gas formations.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

PTEN vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.3× larger
RMD
$1.4B
$1.1B
PTEN
Growing faster (revenue YoY)
RMD
RMD
+23.7% gap
RMD
11.0%
-12.7%
PTEN
Higher net margin
RMD
RMD
29.8% more per $
RMD
27.6%
-2.2%
PTEN
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.8%
-8.4%
PTEN

Income Statement — Q1 FY2026 vs Q4 FY2026

Metric
PTEN
PTEN
RMD
RMD
Revenue
$1.1B
$1.4B
Net Profit
$-24.5M
$392.6M
Gross Margin
61.8%
Operating Margin
34.6%
Net Margin
-2.2%
27.6%
Revenue YoY
-12.7%
11.0%
Net Profit YoY
-170.8%
13.9%
EPS (diluted)
$-0.06
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTEN
PTEN
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.1B
$1.4B
Q4 25
$1.1B
$1.4B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$1.3B
$1.3B
Q4 24
$1.1B
$1.3B
Q3 24
$1.3B
$1.2B
Net Profit
PTEN
PTEN
RMD
RMD
Q2 26
$392.6M
Q1 26
$-24.5M
$398.7M
Q4 25
$-9.2M
$392.6M
Q3 25
$-36.4M
$348.5M
Q2 25
$-49.1M
$379.7M
Q1 25
$1.0M
$365.0M
Q4 24
$-51.4M
$344.6M
Q3 24
$-978.8M
$311.4M
Gross Margin
PTEN
PTEN
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Operating Margin
PTEN
PTEN
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
-0.0%
34.6%
Q3 25
-2.4%
33.4%
Q2 25
-2.4%
33.7%
Q1 25
1.3%
33.0%
Q4 24
-2.7%
32.5%
Q3 24
-73.8%
31.6%
Net Margin
PTEN
PTEN
RMD
RMD
Q2 26
27.6%
Q1 26
-2.2%
27.9%
Q4 25
-0.8%
27.6%
Q3 25
-3.1%
26.1%
Q2 25
-4.1%
28.2%
Q1 25
0.1%
28.3%
Q4 24
-4.5%
26.9%
Q3 24
-72.9%
25.4%
EPS (diluted)
PTEN
PTEN
RMD
RMD
Q2 26
$2.68
Q1 26
$-0.06
$2.74
Q4 25
$-0.01
$2.68
Q3 25
$-0.10
$2.37
Q2 25
$-0.13
$2.58
Q1 25
$0.00
$2.48
Q4 24
$-0.10
$2.34
Q3 24
$-2.50
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTEN
PTEN
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$3.2B
$6.3B
Total Assets
$5.4B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTEN
PTEN
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$418.5M
$1.4B
Q3 25
$184.8M
$1.4B
Q2 25
$183.8M
$1.2B
Q1 25
$223.1M
$932.7M
Q4 24
$239.2M
$521.9M
Q3 24
$113.4M
$426.4M
Total Debt
PTEN
PTEN
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$1.2B
$403.9M
Q3 25
$1.2B
$408.7M
Q2 25
$1.2B
$658.4M
Q1 25
$1.2B
$663.1M
Q4 24
$1.2B
$662.9M
Q3 24
$1.2B
$667.6M
Stockholders' Equity
PTEN
PTEN
RMD
RMD
Q2 26
$6.3B
Q1 26
$3.2B
$6.5B
Q4 25
$3.2B
$6.3B
Q3 25
$3.2B
$6.1B
Q2 25
$3.3B
$6.0B
Q1 25
$3.4B
$5.5B
Q4 24
$3.5B
$5.3B
Q3 24
$3.6B
$5.2B
Total Assets
PTEN
PTEN
RMD
RMD
Q2 26
$8.5B
Q1 26
$5.4B
$8.8B
Q4 25
$5.6B
$8.5B
Q3 25
$5.5B
$8.3B
Q2 25
$5.6B
$8.2B
Q1 25
$5.8B
$7.6B
Q4 24
$5.8B
$7.1B
Q3 24
$6.0B
$7.2B
Debt / Equity
PTEN
PTEN
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
0.38×
0.06×
Q3 25
0.38×
0.07×
Q2 25
0.37×
0.11×
Q1 25
0.36×
0.12×
Q4 24
0.36×
0.13×
Q3 24
0.35×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTEN
PTEN
RMD
RMD
Operating Cash FlowLast quarter
$63.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTEN
PTEN
RMD
RMD
Q2 26
Q1 26
$63.9M
Q4 25
$397.5M
$339.7M
Q3 25
$215.8M
$457.3M
Q2 25
$139.7M
$538.8M
Q1 25
$208.1M
$578.7M
Q4 24
$315.8M
$308.6M
Q3 24
$296.3M
$325.5M
Free Cash Flow
PTEN
PTEN
RMD
RMD
Q2 26
Q1 26
Q4 25
$259.0M
$311.2M
Q3 25
$71.3M
$414.4M
Q2 25
$-4.5M
$508.2M
Q1 25
$46.3M
$557.9M
Q4 24
$175.5M
$288.0M
Q3 24
$115.7M
$307.7M
FCF Margin
PTEN
PTEN
RMD
RMD
Q2 26
Q1 26
Q4 25
22.6%
21.9%
Q3 25
6.1%
31.0%
Q2 25
-0.4%
37.7%
Q1 25
3.7%
43.2%
Q4 24
15.3%
22.5%
Q3 24
8.6%
25.1%
Capex Intensity
PTEN
PTEN
RMD
RMD
Q2 26
Q1 26
4.9%
Q4 25
12.1%
2.0%
Q3 25
12.3%
3.2%
Q2 25
11.9%
2.3%
Q1 25
12.8%
1.6%
Q4 24
12.2%
1.6%
Q3 24
13.5%
1.5%
Cash Conversion
PTEN
PTEN
RMD
RMD
Q2 26
Q1 26
Q4 25
0.87×
Q3 25
1.31×
Q2 25
1.42×
Q1 25
207.11×
1.59×
Q4 24
0.90×
Q3 24
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons